To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
Open KHI Workshop - "Understanding Patients' Preferences: Stimulating Medical Device Development in Kidney Disease"
This workshop will bring together patients, care partners, scientists, doctors, nurses, technicians, and companies to hear what is important to patients, and to think about how those ideas can be measured and used by the companies that are developing new medical devices. The workshop will balance education and teaching with small group discussion.
For more information including registration, housing, patient travel services and a limited number of travel grants for patients, family members and their care partners, please visit the workshop's page.
Third Annual KHI Stakeholders Meeting
KHI brings together its members throughout the year to connect stakeholders across different fields, share ideas, collect feedback, and collaborate on new projects. KHI members are invited to attend the Annual KHI Stakeholders Meeting held in each spring.
KHI is exited to announce that the Third Annual KHI Stakeholders Meeting will take place May 20-21, 2015 at the Hyatt Regency in Bethesda, MD.
To view the official save the date, please click here.
KHI Patient Preferences Webinar – April 2015
If you were unable to attend one of the patient preferences webinars, we have prepared our PowerPoint slides for your download and review.
Please click here to view the slides that were used during the webinar.
You can also find more information about the webinar on its page in the Patient Info section of the KHI website.
KHI Inaugural Review 2012-2014
On behalf of the Board of Directors, we would like to thank the KHI membership for their participation in KHI, which has seen its membership grow from 47 organizations in September 2013, to 70 organizations in December 2014. The membership has worked diligently through KHI to improve patient safety and promote the development of optimal therapies for diseases that affect kidneys and the quality of life for millions of people.
KHI has made impressive strides in its two years of existence and its early progress gives kidney patients hope for a better tomorrow, and emphasizes that real advances can be made by bringing together every stakeholder in the kidney community.
Again, thank you for your support of KHI and commitment to changing the course of kidney disease.
View the KHI Inaugural Review 2012-2014
KHI Project Portal Submissions
KHI seeks to advance its mission through innovative, collaborative projects that seek input from and bring together members across all areas of the kidney community.
We encourage KHI members to submit their ideas for projects via the KHI project portal, which is opened at various times throughout the year. If you are interested in submitting a proposal, please visit the Project Submission page.
Call for Workgroups
Starting in August 2013, KHI project concepts will be submitted by KHI members several times a year. At the close of each submission cycle, the KHI Board of Directors endorses projects after a simple review based on three criteria: meeting KHI mission, impact, and feasibility.
KHI workgroups will be selected via a small sub-group of the KHI Board of Directors. Click here to review the process for workgroup selection as well as the current selection sub-group.
Following is a list of current opportunities for KHI members to volunteer their service on a project workgroup. Click on the title for more information and details on how to volunteer.
Involvement in workgroups is on a voluntary basis with no compensation provided. All workgroup members are required to submit a disclosure with their application. Click here to review KHI's conflict of interest policy.
CJASN Special Feature
Read the press release announcing the new partnership:
Watch the Video
ASN Executive Director Tod Ibrahim provides an update on the early success of the Kidney Health Initiative. Watch video »
ASN President Ronald Falk, MD, FASN discusses the Society's collaboration with the FDA. Watch video »
Listen to Podcasts
Announcing Kidney Health Initiative (KHI)
This Kidney News podcast features ASN Executive Director Tod Ibrahim's interview with ASN President Ronald J. Falk, MD, FASN, on the Kidney Health Initiative (KHI), a new partnership between ASN and the U.S. Food and Drug Administration to advance kidney health. Dr. Falk describes how KHI will collaborate with patient support groups, professional organizations, industry groups and other stakeholders to foster development of new therapeutics and ensure the safety of drugs, devices, biologics, and food products for patients with kidney disease. Posted September 27, 2012.
Kidney Health Initiative: Creating a Bright Future
Renal Support Network's KidneyTalk, "Kidney Health Initiative: Creating a Bright Future" with KHI co-chair Prabir Roy-Chaudhury, MD, PhD, FASN. Posted March 20, 2014.
If you have any questions about KHI, or would like more information about becoming a member, please contact email@example.com.